Viatris, which Pfizer created in 2020, voluntarily withdrew extended-release products made at a plant in Ireland after an ...

A specific lot of the widely prescribed anti-anxiety drug Xanax has been recalled nationwide for not passing quality control tests according to the Food and Drug Administration.

In a fresh drug safety alert underscoring continued regulatory vigilance, 48 batches of drugs, medical devices, and allied ...

The Commissionerate of Food Safety and Drug Control, Rajasthan has issued a public alert after laboratory testing identified ...

A batch of the popular anti-anxiety medication Xanax has been recalled because it may not properly dissolve in the body, according to the U.S. Food and Drug Administration enforcement report. Viatris, ...

Viatris initiated a voluntary recall of Xanax XR Lot 8177156 on March 17 after testing showed the tablets did not meet required dissolution specifications. The Food and Drug Administration has listed ...

Add Yahoo as a preferred source to see more of our stories on Google. A batch of the popular anti-anxiety medication Xanax ...

Prioritising public health and patient safety, the Commissionerate of Food Safety and Drug Control, Rajasthan, has issued an ...

A widely used anti-anxiety drug has come under scrutiny after US regulators announced a voluntary recall of a specific batch of Xanax XR. The affected tablets failed a dissolution test, meaning they ...

The anxiety medication is being recalled due to "failed dissolution specifications." ...

The FDA has confirmed a nationwide Class II recall of a specific lot of Xanax XR (alprazolam extended-release) after it failed dissolution tests, raising concerns about dosage consistency and ...

Bottles of a popular anxiety medication are under recall nationwide for failing to meet dissolution requirements, the Food and Drug Administration said. In a recall notice on April 8, pharmaceutical ...